T. Rowe Price Investment Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

T. Rowe Price Investment Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,926,407	Closed	-$61.9M	–	669
2023 Q4	$61.9M	Sell	3,926,407 -909,244	-19%	-$8.76M	0.04%	359
2023 Q3	$37.5M	Sell	4,835,651 -99,469	-2%	-$825K	0.03%	407
2023 Q2	$49M	Buy	4,935,120 +267,735	+6%	+$2.14M	0.03%	378
2023 Q1	$27.1M	Buy	4,667,385 +203,860	+5%	+$1.76M	0.02%	440
2022 Q4	$35.4M	Buy	4,463,525 +1,148,465	+35%	+$4.93M	0.03%	399
2022 Q3	$10.5M	Buy	+3,315,060	New	+$20.7M	0.01%	495

T. Rowe Price Investment Management's ICVX Position: Q1 2024 in Review

T. Rowe Price Investment Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 3,926,407 shares — an estimated $61.9M sold.

T. Rowe Price Investment Management first reported a position in ICVX in Q3 2022 and held it in 6 quarters. The position peaked at $61.9M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

T. Rowe Price Investment Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
T. Rowe Price Investment Management sold 3,926,407 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $61.9M.
T. Rowe Price Investment Management first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
T. Rowe Price Investment Management's Icosavax, Inc. Common Stock position peaked at $61.9M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2024, filed 15 May 2024.